Financials Médica Sur, S.A.B. de C.V.
Equities
MEDICA B
MXP510121215
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38 MXN | -2.09% | -4.06% | -6.47% |
Valuation
Fiscal Period: December | 2019 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 125 | 192.5 | 234.2 | 227.8 | - | - |
Enterprise Value (EV) 2 | 187.2 | 182 | 234.2 | 236.2 | 237.8 | 236.4 |
P/E ratio | - | - | - | - | - | - |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.69 x | 0.99 x | 1.05 x | 0.98 x | 0.94 x | 0.89 x |
EV / Revenue | 1.04 x | 0.93 x | 1.05 x | 1.02 x | 0.99 x | 0.92 x |
EV / EBITDA | 5.43 x | 4.83 x | 4.79 x | 4.88 x | 4.67 x | 4.27 x |
EV / FCF | - | 43,053,996 x | - | - | 10,032,144 x | 8,650,184 x |
FCF Yield | - | 0% | - | - | 0% | 0% |
Price to Book | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 123,270 | 107,939 | 107,939 | 107,939 | - | - |
Reference price 3 | 21.49 | 37.20 | 40.63 | 38.00 | 38.00 | 38.00 |
Announcement Date | 2/21/20 | 4/17/23 | 2/23/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | 180.5 | - | 195.2 | 222.8 | 232.3 | 241.3 | 256.1 |
EBITDA 1 | 34.46 | - | 37.67 | 48.89 | 48.45 | 50.98 | 55.42 |
EBIT 1 | 17.51 | - | 29.03 | 39.25 | 38.41 | 40.17 | 43.95 |
Operating Margin | 9.7% | - | 14.87% | 17.61% | 16.54% | 16.64% | 17.16% |
Earnings before Tax (EBT) 1 | - | - | 34.19 | 40.01 | 37.92 | 39.78 | 43.68 |
Net income 1 | - | 59.04 | 47.93 | 34.26 | 26.56 | 27.87 | 30.56 |
Net margin | - | - | 24.56% | 15.38% | 11.43% | 11.55% | 11.93% |
EPS | - | - | - | - | - | - | - |
Free Cash Flow | - | - | 4.227 | - | - | 23.7 | 27.33 |
FCF margin | - | - | 2.17% | - | - | 9.82% | 10.67% |
FCF Conversion (EBITDA) | - | - | 11.22% | - | - | 46.5% | 49.31% |
FCF Conversion (Net income) | - | - | 8.82% | - | - | 85.04% | 89.41% |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 2/21/20 | 2/21/22 | 4/17/23 | 2/23/24 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt 1 | 62.2 | - | - | - | 8.4 | 9.99 | 8.56 |
Net Cash position 1 | - | - | 10.5 | - | - | - | - |
Leverage (Debt/EBITDA) | 1.806 x | - | - | - | 0.1733 x | 0.1959 x | 0.1545 x |
Free Cash Flow | - | - | 4.23 | - | - | 23.7 | 27.3 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex | - | - | - | - | - | 15 | 15.9 |
Capex / Sales | - | - | - | - | - | 6.21% | 6.19% |
Announcement Date | 2/21/20 | 2/21/22 | 4/17/23 | 2/23/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.47% | 245M | |
+16.49% | 82.59B | |
-29.52% | 69.86B | |
0.00% | 26.5B | |
-13.29% | 16.61B | |
+1.03% | 17.29B | |
+1.57% | 15.56B | |
+71.63% | 13.2B | |
+1.53% | 12.75B | |
+70.68% | 12.6B |
- Stock Market
- Equities
- MEDICA B Stock
- Financials Médica Sur, S.A.B. de C.V.